Endometrial tumorigenesis in Pten +/- mice is independent of coexistence of estrogen and estrogen receptor α

American Journal of Pathology

Volumn 180, Issue 6, 2012, Pages 2536-2547

  Joshi, Ayesha ^a   Wang, Hong ^a   Jiang, Gaofeng ^a   Douglas, Wayne ^a   Chan, Joanna S Y ^a   Korach, Kenneth S ^b   Ellenson, Lora H ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INVASION; CARCINOGENESIS; CONTROLLED STUDY; DISEASE SEVERITY; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; FEMALE; GENE DELETION; GENETIC ASSOCIATION; GENETIC ENGINEERING; HETEROZYGOTE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OVARIECTOMY; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN D1; DISEASE PROGRESSION; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGENS; FEMALE; GENE DELETION; GLYCOGEN SYNTHASE KINASE 3; MICE; MICE, TRANSGENIC; NEOPLASM INVASIVENESS; OVARIECTOMY; PRECANCEROUS CONDITIONS; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION;

EID: 84861638946     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.03.006     Document Type: Article

References (48)

1. A. Di Cristofano, L.H. Ellenson Endometrial carcinoma Annu Rev Pathol 2 2007 57 85
2. J.I. Risinger, A.K. Hayes, A. Berchuck, J.C. Barrett PTEN/MMAC1 mutations in endometrial cancers Cancer Res 57 1997 4736 4738
3. H. Tashiro, M.S. Blazes, R. Wu, K.R. Cho, S. Bose, S.I. Wang, J. Li, R. Parsons, L.H. Ellenson Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies Cancer Res 57 1997 3935 3940
4. R.L. Levine, C.B. Cargile, M.S. Blazes, B. van Rees, R.J. Kurman, L.H. Ellenson PTEN mutations and microsatellite instability in complex atypical hyperplasia, a precursor lesion to uterine endometrioid carcinoma Cancer Res 58 1998 3254 3258
5. G.L. Maxwell, J.I. Risinger, C. Gumbs, H. Shaw, R.C. Bentley, J.C. Barrett, A. Berchuck, P.A. Futreal Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias Cancer Res 58 1998 2500 2503
6. J.F. Couse, K.S. Korach Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev 20 1999 358 417
7. S. Ellmann, H. Sticht, F. Thiel, M.W. Beckmann, R. Strick, P.L. Strissel Estrogen and progesterone receptors: from molecular structures to clinical targets Cell Mol Life Sci 66 2009 2405 2426
8. J.F. Couse, J. Lindzey, K. Grandien, J.A. Gustafsson, K.S. Korach Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse Endocrinology 138 1997 4613 4621
9. A.A. Donjacour, G.R. Cunha Stromal regulation of epithelial function Cancer Treat Res 53 1991 335 364
10. P.S. Cooke, D.L. Buchanan, D.B. Lubahn, G.R. Cunha Mechanism of estrogen action: lessons from the estrogen receptor-alpha knockout mouse Biol Reprod 59 1998 470 475
11. P.S. Cooke, D.L. Buchanan, P. Young, T. Setiawan, J. Brody, K.S. Korach, J. Taylor, D.B. Lubahn, G.R. Cunha Stromal estrogen receptors mediate mitogenic effects of estradiol on uterine epithelium Proc Natl Acad Sci U S A 94 1997 6535 6540
12. G.R. Cunha, P.S. Cooke, T. Kurita Role of stromal-epithelial interactions in hormonal responses Arch Histol Cytol 67 2004 417 434
13. L. Salmena, A. Carracedo, P.P. Pandolfi Tenets of PTEN tumor suppression Cell 133 2008 403 414
14. D.M. Ignar-Trowbridge, A.R. Hughes, J.W. Putney Jr, J.A. McLachlan, K.S. Korach Diethylstilbestrol stimulates persistent phosphatidylinositol lipid turnover by an estrogen receptor-mediated mechanism in immature mouse uterus Endocrinology 129 1991 2423 2430
15. L.C. Cantley The phosphoinositide 3-kinase pathway Science 296 2002 1655 1657
16. M. Sun, J.E. Paciga, R.I. Feldman, Z. Yuan, D. Coppola, Y.Y. Lu, S.A. Shelley, S.V. Nicosia, J.Q. Cheng Phosphatidylinositol-3-OH kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor alpha (ERalpha) via interaction between ERalpha and PI3K Cancer Res 61 2001 5985 5991
17. T. Simoncini, A. Hafezi-Moghadam, D.P. Brazil, K. Ley, W.W. Chin, J.K. Liao Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase Nature 407 2000 538 541
18. R.A. Campbell, P. Bhat-Nakshatri, N.M. Patel, D. Constantinidou, S. Ali, H. Nakshatri Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance J Biol Chem 276 2001 9817 9824
19. A. Vilgelm, Z. Lian, H. Wang, S.L. Beauparlant, A. Klein-Szanto, L.H. Ellenson, A. Di Cristofano Akt-mediated phosphorylation and activation of estrogen receptor alpha is required for endometrial neoplastic transformation in Pten+/- mice Cancer Res 66 2006 3375 3380
20. E.R. Levin Nuclear receptor versus plasma membrane oestrogen receptor Novartis Found Symp 230 2000 41 50 discussion 50-45
21. K.M. Coleman, C.L. Smith Intracellular signaling pathways: nongenomic actions of estrogens and ligand-independent activation of estrogen receptors Front Biosci 6 2001 D1379 D1391
22. J.G. Moggs, G. Orphanides Estrogen receptors: orchestrators of pleiotropic cellular responses EMBO Rep 2 2001 775 781
23. R.R. Newbold, B.C. Bullock, J.A. McLachlan Uterine adenocarcinoma in mice following developmental treatment with estrogens: a model for hormonal carcinogenesis Cancer Res 50 1990 7677 7681
24. H. Wang, W. Douglas, M. Lia, W. Edelmann, R. Kucherlapati, K. Podsypanina, R. Parsons, L.H. Ellenson DNA mismatch repair deficiency accelerates endometrial tumorigenesis in Pten heterozygous mice Am J Pathol 160 2002 1481 1486
25. A. Fyles, G. Wood, M. Li, A.S. Manoukian, K. Gowing, R. Khokha, W. Chapman, M.S. Tsao Neither ovariectomy nor progestin treatment prevents endometrial neoplasia in pten+/- mice Gynecol Oncol 108 2008 395 401
26. M. Begum, H. Tashiro, H. Katabuchi, A. Suzuki, R.J. Kurman, H. Okamura Neonatal estrogenic exposure suppresses PTEN-related endometrial carcinogenesis in recombinant mice Lab Invest 86 2006 286 296
27. D.A. Cross, D.R. Alessi, P. Cohen, M. Andjelkovich, B.A. Hemmings Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B Nature 378 1995 785 789
28. P.C. van Weeren, K.M. de Bruyn, A.M. de Vries-Smits, J. van Lint, B.M. Burgering Essential role for protein kinase B (PKB) in insulin-induced glycogen synthase kinase 3 inactivation Characterization of dominant-negative mutant of PKB J Biol Chem 273 1998 13150 13156
29. J.A. Diehl, M. Cheng, M.F. Roussel, C.J. Sherr Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization Genes Dev 12 1998 3499 3511
30. A.K. Srivastava, S.K. Pandey Potential mechanism(s) involved in the regulation of glycogen synthesis by insulin Mol Cell Biochem 182 1998 135 141
31. B. Chen, H. Pan, L. Zhu, Y. Deng, J.W. Pollard Progesterone inhibits the estrogen-induced phosphoinositide 3-kinase->AKT->GSK-3beta->cyclin D1->pRB pathway to block uterine epithelial cell proliferation Mol Endocrinol 19 2005 1978 1990
32. J.F. Couse, V.L. Davis, R.B. Hanson, W.N. Jefferson, J.A. McLachlan, B.C. Bullock, R.R. Newbold, K.S. Korach Accelerated onset of uterine tumors in transgenic mice with aberrant expression of the estrogen receptor after neonatal exposure to diethylstilbestrol Mol Carcinog 19 1997 236 242
33. J.V. Lacey Jr, G.L. Mutter, B.M. Ronnett, O.B. Ioffe, M.A. Duggan, B.B. Rush, A.G. Glass, D.A. Richesson, N. Chatterjee, B. Langholz, M.E. Sherman PTEN expression in endometrial biopsies as a marker of progression to endometrial carcinoma Cancer Res 68 2008 6014 6020
34. M.P. Hayes, H. Wang, R. Espinal-Witter, W. Douglas, G.J. Solomon, S.J. Baker, L.H. Ellenson PIK3CA and PTEN mutations in uterine endometrioid carcinoma and complex atypical hyperplasia Clin Cancer Res 12 2006 5932 5935
35. M. Wehling, R. Losel Non-genomic steroid hormone effects: membrane or intracellular receptors? J Steroid Biochem Mol Biol 102 2006 180 183
36. M.J. Kelly, E.R. Levin Rapid actions of plasma membrane estrogen receptors Trends Endocrinol Metab 12 2001 152 156
37. O. Wada-Hiraike, H. Hiraike, H. Okinaga, O. Imamov, R.P. Barros, A. Morani, Y. Omoto, M. Warner, J.A. Gustafsson Role of estrogen receptor beta in uterine stroma and epithelium: Insights from estrogen receptor beta-/- mice Proc Natl Acad Sci U S A 103 2006 18350 18355
38. S.C. Hewitt, G.E. Kissling, K.E. Fieselman, F.L. Jayes, K.E. Gerrish, K.S. Korach Biological and biochemical consequences of global deletion of exon 3 from the ER alpha gene FASEB J 24 2010 4660 4667
39. P.S. Tanwar, L. Zhang, D.J. Roberts, J.M. Teixeira Stromal deletion of the APC tumor suppressor in mice triggers development of endometrial cancer Cancer Res 71 2011 1584 1596
40. T. Kurita, K.J. Lee, P.S. Cooke, J.A. Taylor, D.B. Lubahn, G.R. Cunha Paracrine regulation of epithelial progesterone receptor by estradiol in the mouse female reproductive tract Biol Reprod 62 2000 821 830
41. W. Winuthayanon, S.C. Hewitt, G.D. Orvis, R.R. Behringer, K.S. Korach Uterine epithelial estrogen receptor alpha is dispensable for proliferation but essential for complete biological and biochemical responses Proc Natl Acad Sci U S A 107 2010 19272 19277
42. L. Altucci, R. Addeo, L. Cicatiello, D. Germano, C. Pacilio, T. Battista, M. Cancemi, V.B. Petrizzi, F. Bresciani, A. Weisz Estrogen induces early and timed activation of cyclin-dependent kinases 4, 5, and 6 and increases cyclin messenger ribonucleic acid expression in rat uterus Endocrinology 138 1997 978 984
43. W. Tong, J.W. Pollard Progesterone inhibits estrogen-induced cyclin D1 and cdk4 nuclear translocation, cyclin E- and cyclin A-cdk2 kinase activation, and cell proliferation in uterine epithelial cells in mice Mol Cell Biol 19 1999 2251 2264
44. J. Liang, J.M. Slingerland Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression Cell Cycle 2 2003 339 345
45. R. Katso, K. Okkenhaug, K. Ahmadi, S. White, J. Timms, M.D. Waterfield Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer Annu Rev Cell Dev Biol 17 2001 615 675
46. J.K. Kim, J.A. Diehl Nuclear cyclin D1: an oncogenic driver in human cancer J Cell Physiol 220 2009 292 296
47. F. Bienvenu, S. Jirawatnotai, J.E. Elias, C.A. Meyer, K. Mizeracka, A. Marson, G.M. Frampton, M.F. Cole, D.T. Odom, J. Odajima, Y. Geng, A. Zagozdzon, M. Jecrois, R.A. Young, X.S. Liu, C.L. Cepko, S.P. Gygi, P. Sicinski Transcriptional role of cyclin D1 in development revealed by a genetic-proteomic screen Nature 463 2010 374 378
48. R.M. Zwijsen, E. Wientjens, R. Klompmaker, J. van der Sman, R. Bernards, R.J. Michalides CDK-independent activation of estrogen receptor by cyclin D1 Cell 88 1997 405 415